217 related articles for article (PubMed ID: 21228927)
1. Phenotypic variations in NF1-associated low grade astrocytomas: possible role for increased mTOR activation in a subset.
Jentoft M; Giannini C; Cen L; Scheithauer BW; Hoesley B; Sarkaria JN; Abell-Aleff PC; Rodriguez EF; Li Y; Rodriguez FJ
Int J Clin Exp Pathol; 2010 Dec; 4(1):43-57. PubMed ID: 21228927
[TBL] [Abstract][Full Text] [Related]
2. Gliomas in neurofibromatosis type 1: a clinicopathologic study of 100 patients.
Rodriguez FJ; Perry A; Gutmann DH; O'Neill BP; Leonard J; Bryant S; Giannini C
J Neuropathol Exp Neurol; 2008 Mar; 67(3):240-9. PubMed ID: 18344915
[TBL] [Abstract][Full Text] [Related]
3. Loss of neurofibromatosis 1 (NF1) gene expression in NF1-associated pilocytic astrocytomas.
Gutmann DH; Donahoe J; Brown T; James CD; Perry A
Neuropathol Appl Neurobiol; 2000 Aug; 26(4):361-7. PubMed ID: 10931370
[TBL] [Abstract][Full Text] [Related]
4. Gene expression profiling of NF-1-associated and sporadic pilocytic astrocytoma identifies aldehyde dehydrogenase 1 family member L1 (ALDH1L1) as an underexpressed candidate biomarker in aggressive subtypes.
Rodriguez FJ; Giannini C; Asmann YW; Sharma MK; Perry A; Tibbetts KM; Jenkins RB; Scheithauer BW; Anant S; Jenkins S; Eberhart CG; Sarkaria JN; Gutmann DH
J Neuropathol Exp Neurol; 2008 Dec; 67(12):1194-204. PubMed ID: 19018242
[TBL] [Abstract][Full Text] [Related]
5. Cancer-related gene expression profiles in NF1-associated pilocytic astrocytomas.
Li J; Perry A; James CD; Gutmann DH
Neurology; 2001 Apr; 56(7):885-90. PubMed ID: 11294925
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA profile of pediatric pilocytic astrocytomas identifies two tumor-specific signatures when compared to non-neoplastic white matter.
Darrigo Júnior LG; Lira RCP; Fedatto PF; Marco Antonio DS; Valera ET; Aguiar S; Yunes JA; Brandalise SR; Neder L; Saggioro FP; Becker AP; de Oliveira RS; Machado HR; Panepucci RA; Tone LG; Scrideli CA
J Neurooncol; 2019 Jan; 141(2):373-382. PubMed ID: 30570705
[TBL] [Abstract][Full Text] [Related]
7. Preliminary observations on genetic alterations in pilocytic astrocytomas associated with neurofibromatosis 1.
Tada K; Kochi M; Saya H; Kuratsu J; Shiraishi S; Kamiryo T; Shinojima N; Ushio Y
Neuro Oncol; 2003 Oct; 5(4):228-34. PubMed ID: 14565158
[TBL] [Abstract][Full Text] [Related]
8. Mutational and expression analysis of the NF1 gene argues against a role as tumor suppressor in sporadic pilocytic astrocytomas.
Wimmer K; Eckart M; Meyer-Puttlitz B; Fonatsch C; Pietsch T
J Neuropathol Exp Neurol; 2002 Oct; 61(10):896-902. PubMed ID: 12387455
[TBL] [Abstract][Full Text] [Related]
9. Activation of mTORC1/mTORC2 signaling in pediatric low-grade glioma and pilocytic astrocytoma reveals mTOR as a therapeutic target.
Hütt-Cabezas M; Karajannis MA; Zagzag D; Shah S; Horkayne-Szakaly I; Rushing EJ; Cameron JD; Jain D; Eberhart CG; Raabe EH; Rodriguez FJ
Neuro Oncol; 2013 Dec; 15(12):1604-14. PubMed ID: 24203892
[TBL] [Abstract][Full Text] [Related]
10. Subependymal giant cell astrocytoma-like astrocytoma: a neoplasm with a distinct phenotype and frequent neurofibromatosis type-1-association.
Palsgrove DN; Brosnan-Cashman JA; Giannini C; Raghunathan A; Jentoft M; Bettegowda C; Gokden M; Lin D; Yuan M; Lin MT; Heaphy CM; Rodriguez FJ
Mod Pathol; 2018 Dec; 31(12):1787-1800. PubMed ID: 29973652
[TBL] [Abstract][Full Text] [Related]
11. Up-regulation of specific NF 1 gene transcripts in sporadic pilocytic astrocytomas.
Platten M; Giordano MJ; Dirven CM; Gutmann DH; Louis DN
Am J Pathol; 1996 Aug; 149(2):621-7. PubMed ID: 8702000
[TBL] [Abstract][Full Text] [Related]
12. Comparative gene expression profile analysis of neurofibromatosis 1-associated and sporadic pilocytic astrocytomas.
Gutmann DH; Hedrick NM; Li J; Nagarajan R; Perry A; Watson MA
Cancer Res; 2002 Apr; 62(7):2085-91. PubMed ID: 11929829
[TBL] [Abstract][Full Text] [Related]
13. Loss of neurofibromin is associated with activation of RAS/MAPK and PI3-K/AKT signaling in a neurofibromatosis 1 astrocytoma.
Lau N; Feldkamp MM; Roncari L; Loehr AH; Shannon P; Gutmann DH; Guha A
J Neuropathol Exp Neurol; 2000 Sep; 59(9):759-67. PubMed ID: 11005256
[TBL] [Abstract][Full Text] [Related]
14. Molecular analysis of astrocytomas presenting after age 10 in individuals with NF1.
Gutmann DH; James CD; Poyhonen M; Louis DN; Ferner R; Guha A; Hariharan S; Viskochil D; Perry A
Neurology; 2003 Nov; 61(10):1397-400. PubMed ID: 14638962
[TBL] [Abstract][Full Text] [Related]
15. Genetic alterations related to BRAF-FGFR genes and dysregulated MAPK/ERK/mTOR signaling in adult pilocytic astrocytoma.
Pathak P; Kumar A; Jha P; Purkait S; Faruq M; Suri A; Suri V; Sharma MC; Sarkar C
Brain Pathol; 2017 Sep; 27(5):580-589. PubMed ID: 27608415
[TBL] [Abstract][Full Text] [Related]
16. Proteomic analysis reveals hyperactivation of the mammalian target of rapamycin pathway in neurofibromatosis 1-associated human and mouse brain tumors.
Dasgupta B; Yi Y; Chen DY; Weber JD; Gutmann DH
Cancer Res; 2005 Apr; 65(7):2755-60. PubMed ID: 15805275
[TBL] [Abstract][Full Text] [Related]
17. Genetic aberrations leading to MAPK pathway activation mediate oncogene-induced senescence in sporadic pilocytic astrocytomas.
Jacob K; Quang-Khuong DA; Jones DT; Witt H; Lambert S; Albrecht S; Witt O; Vezina C; Shirinian M; Faury D; Garami M; Hauser P; Klekner A; Bognar L; Farmer JP; Montes JL; Atkinson J; Hawkins C; Korshunov A; Collins VP; Pfister SM; Tabori U; Jabado N
Clin Cancer Res; 2011 Jul; 17(14):4650-60. PubMed ID: 21610151
[TBL] [Abstract][Full Text] [Related]
18. Anaplastic astrocytoma with piloid features, a novel molecular class of IDH wildtype glioma with recurrent MAPK pathway, CDKN2A/B and ATRX alterations.
Reinhardt A; Stichel D; Schrimpf D; Sahm F; Korshunov A; Reuss DE; Koelsche C; Huang K; Wefers AK; Hovestadt V; Sill M; Gramatzki D; Felsberg J; Reifenberger G; Koch A; Thomale UW; Becker A; Hans VH; Prinz M; Staszewski O; Acker T; Dohmen H; Hartmann C; Mueller W; Tuffaha MSA; Paulus W; Heß K; Brokinkel B; Schittenhelm J; Monoranu CM; Kessler AF; Loehr M; Buslei R; Deckert M; Mawrin C; Kohlhof P; Hewer E; Olar A; Rodriguez FJ; Giannini C; NageswaraRao AA; Tabori U; Nunes NM; Weller M; Pohl U; Jaunmuktane Z; Brandner S; Unterberg A; Hänggi D; Platten M; Pfister SM; Wick W; Herold-Mende C; Jones DTW; von Deimling A; Capper D
Acta Neuropathol; 2018 Aug; 136(2):273-291. PubMed ID: 29564591
[TBL] [Abstract][Full Text] [Related]
19. Molecular characterization of disseminated pilocytic astrocytomas.
Gessi M; Engels AC; Lambert S; Rothämel T; von Hornstein S; Collins VP; Denkhaus D; Gnekow A; Pietsch T
Neuropathol Appl Neurobiol; 2016 Apr; 42(3):273-8. PubMed ID: 26084390
[TBL] [Abstract][Full Text] [Related]
20. Alternative lengthening of telomeres, ATRX loss and H3-K27M mutations in histologically defined pilocytic astrocytoma with anaplasia.
Rodriguez FJ; Brosnan-Cashman JA; Allen SJ; Vizcaino MA; Giannini C; Camelo-Piragua S; Webb M; Matsushita M; Wadhwani N; Tabbarah A; Hamideh D; Jiang L; Chen L; Arvanitis LD; Alnajar HH; Barber JR; Rodríguez-Velasco A; Orr B; Heaphy CM
Brain Pathol; 2019 Jan; 29(1):126-140. PubMed ID: 30192422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
